Allergy Medicine

Anti-Human Immunoglobulin E Antibodies May Have Allergy Treatment Applications

Published in Monoclonal Antibodies Weekly, January 19th, 2000

Scientists with Peptide Therapeutics, Ltd., Cambridge, UK, have identified a mouse monoclonal antibody whose functional profile indicates it may have potential in allergy treatments.

In a series of presentations to the Joint Congress of the British Society for Immunology and the British Society for Allergy and Clinical Immunology held November 30 - December 3, 1999, in Harrogatte, UK, Peptide Therapeutics researchers described their studies on the characterization of novel anti-human immunoglobulin E (IgE) antibodies.

Sean Mason and colleagues reported that mouse monoclonal antibody PTmAb0011 exhibits specificity for human IgE, "showing no...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Monoclonal Antibodies Weekly

Source: Monoclonal Antibodies Weekly (2000-01-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry